Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: A mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies

Journal of Autoimmunity

Volumn 36, Issue 1, 2011, Pages 9-15

  Bayry, Jagadeesh ^a,b   Fournier, Emilie M ^a,b   Maddur, Mohan S ^a,b   Vani, Janakiraman ^a,b   Wootla, Bharath ^a,b   Sibéril, Sophie ^a,b   Dimitrov, Jordan D ^a,b   Lacroix Desmazes, Sébastien ^a,b   Berdah, Mikael ^c   Crabol, Yoann ^d   Oksenhendler, Eric ^e   Lévy, Yves ^a,f   Mouthon, Luc ^a,d   Sautès Fridman, Catherine ^a,b   Hermine, Olivier ^g,h   Kaveri, Srini V ^a,b  

^a INSERM   (France)

^b CENTRE DE RECHERCHE DES CORDELIERS   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e SAINT LOUIS HOSPITAL   (France)

^f FACULTÉ DE MÉDECINE   (France)

^g CNRS   (France)

^h HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HUMAN IMMUNOGLOBULIN; IMMUNOGLOBULIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; TRANSCRIPTION FACTOR T BET;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; CONCENTRATION RESPONSE; DRUG MECHANISM; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ADULT; AGED; ANTIBODY FORMATION; B-LYMPHOCYTES; CELL PROLIFERATION; CELL SEPARATION; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 79151469181     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2010.09.006     Document Type: Article

References (65)

1. Cunningham-Rundles C., Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999, 92:34-48.
2. Bayry J., Hermine O., Webster D.A., Levy Y., Kaveri S.V. Common variable immunodeficiency: the immune system in chaos. Trends Mol Med 2005, 11:370-376.
3. Park M.A., Li J.T., Hagan J.B., Maddox D.E., Abraham R.S. Common variable immunodeficiency: a new look at an old disease. Lancet 2008, 372:489-502.
4. Mackay I.R., Leskovsek N.V., Rose N.R. The odd couple: a fresh look at autoimmunity and immunodeficiency. J Autoimmun 2010, 35:199-205.
5. Grimbacher B., Hutloff A., Schlesier M., Glocker E., Warnatz K., Drager R., et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003, 4:261-268.
6. Salzer U., Chapel H.M., Webster A.D., Pan-Hammarstrom Q., Schmitt-Graeff A., Schlesier M., et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 2005, 37:820-828.
7. Castigli E., Wilson S.A., Garibyan L., Rachid R., Bonilla F., Schneider L., et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 2005, 37:829-834.
8. Warnatz K., Bossaller L., Salzer U., Skrabl-Baumgartner A., Schwinger W., van der Burg M., et al. Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. Blood 2006, 107:3045-3052.
9. Garibyan L., Lobito A.A., Siegel R.M., Call M.E., Wucherpfennig K.W., Geha R.S. Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID). J Clin Invest 2007, 117:1550-1557.
10. Zhang L., Radigan L., Salzer U., Behrens T.W., Grimbacher B., Diaz G., et al. Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes. J Allergy Clin Immunol 2007, 120:1178-1185.
11. Warnatz K., Denz A., Drager R., Braun M., Groth C., Wolff-Vorbeck G., et al. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 2002, 99:1544-1551.
12. Bayry J., Lacroix-Desmazes S., Kazatchkine M.D., Galicier L., Lepelletier Y., Webster D., et al. Common variable immunodeficiency is associated with defective functions of dendritic cells. Blood 2004, 104:2441-2443.
13. Cunningham-Rundles C., Radigan L., Knight A.K., Zhang L., Bauer L., Nakazawa A. TLR9 activation is defective in common variable immune deficiency. J Immunol 2006, 176:1978-1987.
14. Wehr C., Kivioja T., Schmitt C., Ferry B., Witte T., Eren E., et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008, 111:77-85.
15. Giovannetti A., Pierdominici M., Mazzetta F., Marziali M., Renzi C., Mileo A.M., et al. Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol 2007, 178:3932-3943.
16. Nonoyama S., Farrington M., Ishida H., Howard M., Ochs H.D. Activated B cells from patients with common variable immunodeficiency proliferate and synthesize immunoglobulin. J Clin Invest 1993, 92:1282-1287.
17. Stewart D.M., McAvoy M.J., Hilbert D.M., Nelson D.L. B lymphocytes from individuals with common variable immunodeficiency respond to B lymphocyte stimulator (BLyS protein) in vitro. Clin Immunol 2003, 109:137-143.
18. Farrington M., Grosmaire L.S., Nonoyama S., Fischer S.H., Hollenbaugh D., Ledbetter J.A., et al. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci U S A 1994, 91:1099-1103.
19. Orange J.S., Hossny E.M., Weiler C.R., Ballow M., Berger M., Bonilla F.A., et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the primary immunodeficiency committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol 2006, 117:S525-S553.
20. Busse P.J., Razvi S., Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 2002, 109:1001-1004.
21. Roifman C.M., Schroeder H., Berger M., Sorensen R., Ballow M., Buckley R.H., et al. Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trial. Int Immunopharmacol 2003, 3:1325-1333.
22. Bayry J., Lacroix-Desmazes S., Kazatchkine M.D., Kaveri S.V. Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action. Nat Clin Pract Rheumatol 2007, 3:262-272.
23. Gold R., Stangel M., Dalakas M.C. Drug insight: the use of intravenous immunoglobulin in neurology - therapeutic considerations and practical issues. Nat Clin Pract Neurol 2007, 3:36-44.
24. Seite J.F., Shoenfeld Y., Youinou P., Hillion S. What is the contents of the magic draft IVIg?. Autoimmun Rev 2008, 7:435-439.
25. Nimmerjahn F., Ravetch J.V. Anti-inflammatory actions of intravenous immunoglobulin. Annu Rev Immunol 2008, 26:513-533.
26. Arnson Y., Shoenfeld Y., Amital H. Intravenous immunoglobulin therapy for autoimmune diseases. Autoimmunity 2009, 42:553-560.
27. Kivity S., Katz U., Daniel N., Nussinovitch U., Papageorgiou N., Shoenfeld Y. Evidence for the use of intravenous immunoglobulins - a review of the literature. Clin Rev Allergy Immunol 2010, 38:201-269.
28. Kazatchkine M.D., Kaveri S.V. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001, 345:747-755.
29. Serrano D., Becker K., Cunningham-Rundles C., Mayer L. Characterization of the T cell receptor repertoire in patients with common variable immunodeficiency: oligoclonal expansion of CD8(+) T cells. Clin Immunol 2000, 97:248-258.
30. Cambronero R., Sewell W.A., North M.E., Webster A.D., Farrant J. Up-regulation of IL-12 in monocytes: a fundamental defect in common variable immunodeficiency. J Immunol 2000, 164:488-494.
31. Martinez-Pomar N., Raga S., Ferrer J., Pons J., Munoz-Saa I., Julia M.R., et al. Elevated serum interleukin (IL)-12p40 levels in common variable immunodeficiency disease and decreased peripheral blood dendritic cells: analysis of IL-12p40 and interferon-gamma gene. Clin Exp Immunol 2006, 144:233-238.
32. Durali D., de Goer de Herve M.G., Giron-Michel J., Azzarone B., Delfraissy J.F., Taoufik Y. In human B cells, IL-12 triggers a cascade of molecular events similar to Th1 commitment. Blood 2003, 102:4084-4089.
33. Grammer A.C., Fischer R., Lee O., Zhang X., Lipsky P.E. Flow cytometric assessment of the signaling status of human B lymphocytes from normal and autoimmune individuals. Arthritis Res Ther 2004, 6:28-38.
34. Cunningham-Rundles C. Autoimmune manifestations in common variable immunodeficiency. J Clin Immunol 2008, 28(Suppl. 1):S42-S45.
35. Invernizzi P. Future directions in genetic for autoimmune diseases. J Autoimmun 2009, 33:1-2.
36. Invernizzi P., Gershwin M.E. The genetics of human autoimmune disease. J Autoimmun 2009, 33:290-299.
37. Invernizzi P., Pasini S., Selmi C., Gershwin M.E., Podda M. Female predominance and X chromosome defects in autoimmune diseases. J Autoimmun 2009, 33:12-16.
38. Andre S., Tough D.F., Lacroix-Desmazes S., Kaveri S.V., Bayry J. Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications. Am J Pathol 2009, 174:1575-1587.
39. Bayry J. Autoimmunity: CTLA-4: a key protein in autoimmunity. Nat Rev Rheumatol 2009, 5:244-245.
40. Hewagama A., Richardson B. The genetics and epigenetics of autoimmune diseases. J Autoimmun 2009, 33:3-11.
41. Pauley K.M., Cha S., Chan E.K. MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun 2009, 32:189-194.
42. Brooks W.H., Le Dantec C., Pers J.O., Youinou P., Renaudineau Y. Epigenetics and autoimmunity. J Autoimmun 2010, 34:J207-J219.
43. Youinou P., Pers J.O., Gershwin M.E., Shoenfeld Y. Geo-epidemiology and autoimmunity. J Autoimmun 2010, 34:J163-J167.
44. Agmon-Levin N., Paz Z., Israeli E., Shoenfeld Y. Vaccines and autoimmunity. Nat Rev Rheumatol 2009, 5:648-652.
45. Bayry J., Lacroix-Desmazes S., Kazatchkine M.D., Hermine O., Tough D.F., Kaveri S.V. Modulation of dendritic cell maturation and function by B lymphocytes. J Immunol 2005, 175:15-20.
46. Chang C., Gershwin M.E. Drugs and autoimmunity-a contemporary review and mechanistic approach. J Autoimmun 2010, 34:J266-J275.
47. Salzer U., Grimbacher B. Common variable immunodeficiency: the power of co-stimulation. Semin Immunol 2006, 18:337-346.
48. Kanegane H., Agematsu K., Futatani T., Sira M.M., Suga K., Sekiguchi T., et al. Novel mutations in a Japanese patient with CD19 deficiency. Genes Immun 2007, 8:663-670.
49. Lee J.J., Rauter I., Garibyan L., Ozcan E., Sannikova T., Dillon S.R., et al. The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function. Blood 2009, 114:2254-2262.
50. Warnatz K., Salzer U., Rizzi M., Fischer B., Gutenberger S., Bohm J., et al. B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci U S A 2009, 106:13945-13950.
51. Malphettes M., Gerard L., Carmagnat M., Mouillot G., Vince N., Boutboul D., et al. Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis 2009, 49:1329-1338.
52. Borte S., Pan-Hammarstrom Q., Liu C., Sack U., Borte M., Wagner U., et al. Interleukin-21 restores immunoglobulin production ex vivo in patients with common variable immunodeficiency and selective IgA deficiency. Blood 2009, 114:4089-4098.
53. Le Pottier L., Bendaoud B., Dueymes M., Daridon C., Youinou P., Shoenfeld Y., et al. BAFF, a new target for intravenous immunoglobulin in autoimmunity and cancer. J Clin Immunol 2007, 27:257-265.
54. Le Pottier L., Sapir T., Bendaoud B., Youinou P., Shoenfeld Y., Pers J.O. Intravenous immunoglobulin and cytokines: focus on tumor necrosis factor family members BAFF and APRIL. Ann N Y Acad Sci 2007, 1110:426-432.
55. Kaveri S.V., Lacroix-Desmazes S., Bayry J. The antiinflammatory IgG. N Engl J Med 2008, 359:307-309.
56. Tha- T., Bayry J., Metselaar H.J., Kaveri S.V., Kwekkeboom J. Modulation of the cellular immune system by intravenous immunoglobulin. Trends Immunol 2008, 29:608-615.
57. Krause I., Wu R., Sherer Y., Patanik M., Peter J.B., Shoenfeld Y. In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations - a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases. Transfus Med 2002, 12:133-139.
58. Bayry J., Lacroix-Desmazes S., Kazatchkine M.D., Kaveri S.V. Intravenous immunoglobulin for infectious diseases: back to the pre-antibiotic and passive prophylaxis era?. Trends Pharmacol Sci 2004, 25:306-310.
59. Sewell W.A., North M.E., Cambronero R., Webster A.D., Farrant J. In vivo modulation of cytokine synthesis by intravenous immunoglobulin. Clin Exp Immunol 1999, 116:509-515.
60. Artac H., Kara R., Reisli I. In vivo modulation of the expressions of Fas and CD25 by intravenous immunoglobulin in common variable immunodeficiency. Clin Exp Med 2010, 10:27-31.
61. Bayry J., Lacroix-Desmazes S., Donkova-Petrini V., Carbonneil C., Misra N., Lepelletier Y., et al. Natural antibodies sustain differentiation and maturation of human dendritic cells. Proc Natl Acad Sci U S A 2004, 101:14210-14215.
62. Bayry J., Lacroix-Desmazes S., Hermine O., Oksenhendler E., Kazatchkine M.D., Kaveri S.V. Amelioration of differentiation of dendritic cells from CVID patients by intravenous immunoglobulin. Am J Med 2005, 118:1439-1440.
63. Seite J.F., Cornec D., Renaudineau Y., Youinou P., Mageed R.A., Hillion S. IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes. Blood 2010, 116:1698-1704.
64. Harris D.P., Haynes L., Sayles P.C., Duso D.K., Eaton S.M., Lepak N.M., et al. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol 2000, 1:475-482.
65. Dardalhon V., Korn T., Kuchroo V.K., Anderson A.C. Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun 2008, 31:252-256.